Salute e Benessere

Trogenix announces £70 million / $95 million Series A financing to drive…

Trogenix's breakthrough Odysseus® platform targets cancer cells to deliver precision therapies with curative “one and done” potential across multiple aggressive, treatment-resistant cancersFinancing round led by IQ Capital with participation from founding investor 4BIO Capital, returning investors Cancer Research Horizons and the National Brain Tumor Society’s Brain Tumor Investment Fund, and new investors Eli Lilly and Company, Meltwind, LongeVC, and Calculus CapitalCancer Research...
Nasdaq GlobeNewswire
06/10/2025

BlueNord: Preliminary Production for September 2025

The base assets, Dan, Gorm, and Halfdan hubs, delivered 19.2 mboepd net to the Company. Dan and Halfdan performed as expected, while the Gorm hub experienced operational challenges related to compressors and the water injection system. The operator is currently working to resolve the issues, and BlueNord expects full production from Gorm to resume in the near term. Preliminary production for third quarter 2025 for the base assets was 20.2 mboepd which is slightly below guidance of 21.0 – 23.0…
PR Newswire
06/10/2025

VALNEVA Declaration of shares and voting rights: September 30, 2025

VALNEVADeclaration of shares and voting rightsSeptember 30, 2025__________________________________________________________________________________________Company name: VALNEVA Registered office: 6 rue Alain Bombard, 44800 Saint-Herblain (France) Regulated market of Euronext Paris - Compartment B Declaration date: October 6, 2025 Number of sharescomposing the share capital of ValnevaTotal number of voting rights including suspended voting rights* Description of the...
Nasdaq GlobeNewswire
06/10/2025

Roche receives CE Mark for AI-based Kidney Klinrisk Algorithm(1) and launches…

Roche, in collaboration with KlinRisk, Inc, has received CE-mark for the first AI-based risk stratification tool for assessment of progressive decline in kidney function.This tool will be launched as part of Roche’s new chronic kidney disease (CKD) algorithm panel to support care across the stages of the disease which affects 700 million people globally.Clinicians can use the CKD panel (Kidney Klinrisk Algorithm and Kidney KFRE Algorithm) to evaluate a patient’s risk of kidney...
Nasdaq GlobeNewswire
06/10/2025

Nyxoah Announces First U.S. Commercial Patients Implanted with Genio® System

Nyxoah Announces First U.S. Commercial Patients Implanted with Genio® SystemEarly Commercial Launch Demonstrates Strong Physician Demand, Successful Pre-Authorizations, and Widespread Payor CoverageMont-Saint-Guibert, Belgium – October 6, 2025 7:00 CET / 1:00 ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH), a medical technology company that develops breakthrough treatment alternatives for Obstructive Sleep Apnea (OSA), today announced that the first U.S. commercial patients have been...
Nasdaq GlobeNewswire
06/10/2025

Fagron receives Brazilian antitrust clearance for Purifarma and Injeplast…

Regulated information - inside information Nazareth (Belgium)/Rotterdam (The Netherlands), 6 October 2025 – 7:00 AM CET Fagron receives Brazilian antitrust clearance for Purifarma and Injeplast acquisitionsFagron, the leading global player in pharmaceutical compounding, announces that the Brazilian competition authority, CADE, has granted clearance for the previously announced acquisitions of Purifarma and Injeplast in Brazil.The clearances represent an important step forward in...
Nasdaq GlobeNewswire
06/10/2025

Why Travel for Wellness: ASICS Reveals 15 Minutes of Movement Can Boost Your…

According to Euromonitor, the global demand for wellness holidays has surged by 33% in the last year [2], with the Global Wellness Institute finding that people spend an average of $1,764 for a week away, 41% more than standard travel.[3] However, new global research by ASICS[4], surveying 11,000 people who recently took a wellness holiday, reveals that whilst people travel on average 1,920km for their wellness holidays[4], they don't always deliver. Two-thirds (67%) said their wellness holiday…
PR Newswire
06/10/2025

EANM'25: Metabolically active visceral fat linked to aggressive endometrial…

Researchers from Haukeland University Hospital and the University of Bergen analysed PET/CT scans of 274 women with endometrial cancer, measuring glucose uptake in visceral fat as an indicator of metabolic activity. They found that women with higher metabolic activity - assessed by average glucose uptake in visceral fat tissue - were more likely to present with advanced stage disease and lymph node metastases. Researchers from Haukeland University Hospital and theUniversity of Bergen...
PR Newswire
05/10/2025

Human Papilloma Virus/HPV Test and Pap Smear/Test Market worth US$3.94 billion…

Browse in-depth TOC on "HPV Testing and Pap Test Market" Browse in-depth TOC on "HPV Testing and Pap Test Market" 311 - Tables 53 - Figures 257 - Pages By test type,the HPV testing and Pap test market is segmented into HPV testing and Pap tests. In 2024, HPV testing accounted for the dominant share of the market. This dominance is attributed to the growing global shift toward HPV testing as the primary screening method for cervical cancer, supported by its higher...
PR Newswire
04/10/2025

2025 "Jiangsu Traditional Chinese Medicine Goes Global" European Cultural Tour…

In his remarks, Zhao Ming, Deputy Director of the Cyberspace Administration of Jiangsu Province, described TCM as a "cultural treasure" of Chinese civilization that embodies the philosophies and health traditions of the East. He noted that Jiangsu has long been a center for TCM development and exchange—from Xu Fu's ancient voyages in search of medicinal herbs to Zheng He's maritime expeditions. In recent years, the "Jiangsu Traditional Chinese Medicine Goes Global" initiative…
PR Newswire
04/10/2025

Publication relating to transparency notifications

REGULATED INFORMATIONPublication relating to transparency notificationsMont-Saint-Guibert(Belgium), October 3, 2025 , 10:30 pm CET / 4:30 pm ET –In accordance with article 14 of the Act of 2 May 2007 on the disclosure of large shareholdings, Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) announces that it received a transparency notification as detailed below.Vestal Point CapitalOn October 1, 2025, Nyxoah received a transparency notification from Vestal Point Capital...
Nasdaq GlobeNewswire
03/10/2025

Cosmos Health Expands Sky Premium Life Into $1Bn+ Kuwait Market; Signs Exclusive…

Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that its subsidiary, SkyPharm S.A., has entered into an exclusive distribution agreement, dated as of September 28, 2025, with Diyar United for the marketing and sale of its Sky Premium Life® line of nutraceuticals in Kuwait.Diyar United is a respected distributor in Kuwait with extensive healthcare experience. Its strong network,...
Nasdaq GlobeNewswire
03/10/2025

Leo Cancer Care Plans to Integrate TibaRay Linacs into Future Grace Photon…

The integration of TibaRay's high-efficiency linac technology will be studied as part of Grace's development program. TibaRay's accelerators are designed to deliver higher dose rates than conventional systems, opening the possibility for new treatment paradigms such as FLASH radiotherapy, while also offering a more compact footprint that aligns well with Leo Cancer Care's upright treatment approach. The integration of TibaRay's high-efficiency linac technology will be studied as part of…
PR Newswire
03/10/2025

Press release: Transparency Notification from Shareholder

Transparency Notification from ShareholderGhent, Belgium – 3 October 2025 – Sequana Medical NV (Euronext Brussels: SEQUA)(the " Company " or " SequanaMedical "), a pioneer in the treatment of drug-resistant fluid overload in liver disease, heart failure and cancer, announces today that it received a transparency notification in relation to the entity listed below, notifying the number of voting rights attached to the shares mentioned next to its name in the table below…
Nasdaq GlobeNewswire
03/10/2025

OXURION : Information on the Total Number of Voting Rights (Denominator)…

Atlas Special Opportunities, LLC has converted 4 convertible bonds in Oxurion resulting in a EUR 100,000 capital increase. This is part of Atlas Special Opportunities, LLC's EUR 20 million Capital Commitment[1]. Leuven, BELGIUM – 3 October, 2025 – 06:00 PM CET – In accordance with article 15 of the Belgian Act of May 2, 2007 on the disclosure of…
Actusnews Wire
03/10/2025

Virbac : Declaration of the number of shares and voting rights 09/2025

DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS Information on the total number of voting rights and of shares representing the share capital (Article 223-16 of the General regulations of the French Financial Market Authority – Autorité des Marchés Financiers)Quotation place: Euronext Paris Compartiment A ISIN code: FR0000031577DateTotal number of shares representing the share capitalTotal number of voting rightsSeptember, 30 20258 390 660Gross total of voting...
Nasdaq GlobeNewswire
03/10/2025

Oral Contraceptive Pills Market Size to Reach US$ 38.16 Bn by 2033, Driven by…

The oral contraceptive pills (OCPs) market is driven by the high prevalence of unintended pregnancies, which account for nearly half of all pregnancies globally. According to WHO (August 2024), around 73 million induced abortions occur annually, with 61% of unintended and 29% of all pregnancies ending in abortion. Alarmingly, 45% of these are unsafe, underscoring the urgent need for reliable and accessible contraceptive options. The oral contraceptive pills (OCPs) market is driven by the high...
PR Newswire
03/10/2025

Evaxion to present new biomarker data for AI-designed personalized cancer…

New biomarker and immune data from the ongoing phase 2 trial with EVX-01 will be presented at the Society for Immunotherapy of Cancer (SITC) 2025 Annual Meeting The data will be the latest of many additions to EVX-01’s strong data packageTwo-year clinical efficacy data from the trial will be presented at the European Society for Medical Oncology (ESMO) 2025 congress on October 17, 2025COPENHAGEN, Denmark, October 3, 2025 - Evaxion A/S (NASDAQ: EVAX) (“Evaxion”), a...
Nasdaq GlobeNewswire
03/10/2025

Animal Health Market Size to Reach US$ 119.44 Bn by 2033, Driven by Rising Pet…

Get a Free Sample PDF Brochure of the Report (Use Corporate Email ID for a Quick Response): https://www.datamintelligence.com/download-sample/animal-health-market Get a Free Sample PDF Brochure of the Report (Use Corporate Email ID for a Quick Response): https://www.datamintelligence.com/download-sample/animal-health-market Browse in-depth TOC on "Oral Contraceptive Pills Market" 62 – Tables 55 – Figures 180 – Pages By product type, the biologics segment from product...
PR Newswire
03/10/2025

Active Pharmaceutical Ingredients (API) Market to Surpass US$ 428.5 Billion by…

Digital & AI-driven transformation – Artificial intelligence, machine learning, and digital twins are being integrated into R&D and manufacturing. These tools optimize synthesis pathways, predict yields, reduce time-to-market, and enable "smart API factories" with real-time quality monitoring. Digital & AI-driven transformation – Artificial intelligence, machine learning, and digital twins are being integrated into R&D and manufacturing. These tools optimize synthesis…
PR Newswire
03/10/2025

Duodenoscopes Market 2025-2030 Forecasts shows 5.5% CAGR, Says Mordor…

Advances in Imaging and AI Advances in Imaging and AI New imaging technologies and AI tools are improving accuracy, enabling earlier detection and fewer missed diagnoses. Flexible scope designs also enhance outcomes in complex cases. These innovations are driving hospitals toward premium systems and raising standards of gastrointestinal care. Growing Preference for Minimally Invasive ERCP Healthcare systems are shifting toward minimally invasive options that cut recovery time and...
PR Newswire
03/10/2025

COSRX Makes History as First Korean Skincare and Haircare Brand to Sponsor Paris…

COSRX's role as an official backstage sponsor of Paris Fashion Week's September main season is a milestone in itself. Traditionally, these shows rely on in-house beauty lines or major global affiliates, leaving little room for outside brands. Verified records confirm that this marks the first time in the 53-year history of Paris Fashion Week that a Korean brand has officially partnered backstage for the September main season. More than a sponsorship, it signals a cultural and industry…
PR Newswire
03/10/2025

Cosentino launches its new Éclos® brand: an innovative generation of mineral…

"Since our founding, we have been committed to leading innovation rather than following trends. Just as we did with Silestone®, Dekton®, and most recently with Hybriq+® technology for Silestone®. Éclos® involves a new turning point for our industry, an evolution that responds to real market needs and anticipates the future," says Pilar Cosentino, Cosentino Group CEO. "Since our founding, we have been committed to leading innovation rather than following trends. Just as we did…
PR Newswire
03/10/2025

Mediso installs true theranostic TheraMAX SPECT/CT at Heidelberg University…

"The TheraMAX expands the imaging capabilities of our department for radioligand therapy. We treat patients with a wide range of novel radiopharmaceuticals labelled with 177Lu or 225Ac, some of them as part of clinical trials for developing improved and more individualized patient care. In addition, the TheraMAX supports our department by increasing the capacity of our department for 99mTc-PSMA scans for radioligand therapy inclusion" said Professor Dr. Clemens Kratochwil, lead…
PR Newswire
03/10/2025
Altri  Comunicati